Ping An Biomedical
Quarterly Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2024-03-31 |
|---|---|---|---|
Cash | 1,172 | 130 | 969 |
Basic Shares | 20,500 | 20,500 | 20,500 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $34,147 | $87,622 | $82,563 | $114,548 |
Gross Profit | 949 | 5,416 | 4,240 | 14,143 |
EBITDA | 473 | 2,198 | 11,605 | |
EBIT | 22 | 1,781 | 11,191 | |
Net Income | -12,829 | -1,284 | -993 | 7,226 |
Net Change In Cash | 34,147 | 87,622 | 82,563 | 114,548 |
Free Cash Flow | -6,427 | 14,630 | -6,082 | 21,063 |
Cash | 1,172 | 130 | 591 | 1,166 |
Basic Shares | 20,500 | 20,500 | 20,500 | 20,500 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.45 |
2025-06-30 | -$0.24 |
2024-12-31 | -$0.08 |
